Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $39.6300 (-6.86%) ($39.6300 - $39.6300) on Wed. Dec. 9, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.28% (three month average) | RSI | 54 | Latest Price | $39.6300(-6.86%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO declines -0.5% a day on average for past five trading days. | Weekly Trend | HALO advances 1% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(51%) IWO(51%) IWM(49%) IWC(46%) ARKG(43%) | Factors Impacting HALO price | HALO will decline at least -1.64% in a week (0% probabilities). VIXM(-31%) VXX(-13%) UUP(-13%) TLT(-0%) TBT(-0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.64% (StdDev 3.28%) | Hourly BBV | -1.5 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | Resistance Level | $39.85 | 5 Day Moving Average | $40.37(-1.83%) | 10 Day Moving Average | $40.37(-1.83%) | 20 Day Moving Average | $39.85(-0.55%) | To recent high | -6.9% | To recent low | 54% | Market Cap | $5.416b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |